Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CAICUN ZHOU")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

Response to pemetrexed rechallenge after acquired resistance of EGFR-TKI in a patient with advanced NSCLCSHUAI LI; FANGYU ZHOU; SHENGXIANG REN et al.Lung cancer. 2014, Vol 84, Num 2, pp 203-205, issn 0169-5002, 3 p.Article

A case of lung adenocarcinoma harboring exon 19 EGFR deletion and EML4-ALK fusion geneXIAOXIA CHEN; JIE ZHANG; QIONG HU et al.Lung cancer. 2013, Vol 81, Num 2, pp 308-310, issn 0169-5002, 3 p.Article

KlF5B-RET Fusions in Chinese Patients With Non―Small Cell Lung CancerWEIJING CAI; CHUNXIA SU; XUEFEI LI et al.Cancer. 2013, Vol 119, Num 8, pp 1486-1494, issn 0008-543X, 9 p.Article

Gefitinib-Resistance Is Related to BIM Expression in Non-Small Cell Lung Cancer Cell LinesHEYAN LI; SONGWEN ZHOU; XUEFEI LI et al.Cancer biotherapy & radiopharmaceuticals. 2013, Vol 28, Num 2, pp 115-123, issn 1084-9785, 9 p.Article

Gene transfer of inhibitor kappaB in human lung cancer cell line NCI-H460 inhibits tumorigenesis and angiogenesis in vivoJIAN NI; TAKAYAMA, Koichi; INOSHIMA, Naoko et al.Anticancer research. 2005, Vol 25, Num 1A, pp 69-77, issn 0250-7005, 9 p.Article

Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapySHENGXIANG REN; SONGWEN ZHOU; FENGYIN WU et al.Lung cancer. 2012, Vol 75, Num 1, pp 102-109, issn 0169-5002, 8 p.Article

Adenovirus-mediated Inhibitor KB Gene Transfer Improves the Chemosensitivity to Anticancer Drugs in Human Lung Cancer In Vitro and In VivoJIAN NI; TAKAYAMA, Koichi; USHIJIMA, Rie et al.Anticancer research. 2008, Vol 28, Num 2A, pp 601-608, issn 0250-7005, 8 p.Article

Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patientsPENG KUANG; CAICUN ZHOU; XUEFEI LI et al.Lung cancer. 2012, Vol 77, Num 2, pp 427-432, issn 0169-5002, 6 p.Article

Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFRSHENGXIANG REN; CHUNXIA SU; YAYI HE et al.International journal of cancer (Print). 2014, Vol 135, Num 12, pp 2962-2971, issn 0020-7136, 10 p.Article

Impact of family history of cancer on the incidence of mutation in epidermal growth factor receptor gene in non-small cell lung cancer patientsYAYI HE; SHUAI LI; FEI ZHOU et al.Lung cancer. 2013, Vol 81, Num 2, pp 162-166, issn 0169-5002, 5 p.Article

Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancerWU, Yi-Long; SHUN LU; XIN WANG et al.Lung cancer. 2014, Vol 85, Num 3, pp 401-407, issn 0169-5002, 7 p.Article

The Bim Deletion Polymorphism Clinical Profile and its Relation With Tyrosine Kinase Inhibitor Resistance in Chinese Patients With Non-Small Cell Lung CancerMINGCHUAN ZHAO; YISHI ZHANG; CAICUN ZHOU et al.Cancer. 2014, Vol 120, Num 15, pp 2299-2307, issn 0008-543X, 9 p.Article

T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patientsWEI LI; SHENGXIANG REN; SHUAI LI et al.Lung cancer. 2014, Vol 84, Num 3, pp 295-300, issn 0169-5002, 6 p.Article

Association of EGFR Mutation or ALK Rearrangement With Expression of DNA Repair and Synthesis Genes in Never-Smoker Women With Pulmonary AdenocarcinomaSHENGXIANG REN; XIAOXIA CHEN; JIE ZHANG et al.Cancer. 2012, Vol 118, Num 22, pp 5588-5594, issn 0008-543X, 7 p.Article

RGD-targeted paramagnetic liposomes for early detection of tumor: In vitro and in vivo studiesWEI LI; BO SU; YINMIN ZHAO et al.European journal of radiology. 2011, Vol 80, Num 2, pp 598-606, issn 0720-048X, 9 p.Article

MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancerBING LI; SHENGXIANG REN; GUANGHUI GAO et al.Lung cancer. 2014, Vol 83, Num 2, pp 146-153, issn 0169-5002, 8 p.Article

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung CancerMOK, Tony S. K; WU, Yi-Long; CHUA-TAN, Marina et al.Journal of clinical oncology. 2009, Vol 27, Num 30, pp 5080-5087, issn 0732-183X, 8 p.Article

  • Page / 1